Efficacy and Safety of SSRIs and SNRIs for Child and Adolescent Psychiatric Disorders
The Carlat Child Psychiatry Report, Volume 9, Number 1, January 2018
Adam Strassberg, MD
Dr. Strassberg has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Since the 2004 FDA black-box warning on all antidepressants for pediatric use, controversy continues over the use of SSRIs and SNRIs in children and adolescents. Both classes of medication are still commonly used for pediatric depressive disorders, anxiety disorders, and obsessive-compulsive disorder.